Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A practical treatment for COVID‐19 and the next pandemic
Jahar Bhattacharya, Robert Booy, Arturo Casadevall, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 11

Showing 11 citing articles:

Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases
Oana-Alina Petrariu, Ilda Czobor Barbu, Adelina-Gabriela Niculescu, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 38
Perspectives of (/memorandum for) systems thinking on COVID‐19 pandemic and pathology
Felix Tretter, Eva M.J. Peters, Joachim P. Sturmberg, et al.
Journal of Evaluation in Clinical Practice (2022) Vol. 29, Iss. 3, pp. 415-429
Open Access | Times Cited: 16
An update on Long COVID
Gary Grohmann, Robert Booy
Microbiology Australia (2024)
Open Access | Times Cited: 2
The Effectiveness of the Third Dose of COVID-19 Vaccine: When Should It Be Performed?
Giacomo Biganzoli, Marco Mendola, Pier Mario Perrone, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 315-315
Open Access | Times Cited: 2
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients
Megan M. Sperry, Tomiko Oskotsky, Ivana Marić, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 5, pp. e1011050-e1011050
Open Access | Times Cited: 5
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
The valley of death: why Australia failed to develop clinically effective drugs in COVID‐19
Jennifer Martin
Internal Medicine Journal (2023) Vol. 53, Iss. 12, pp. 2175-2179
Open Access | Times Cited: 2
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients
Megan M. Sperry, Tomiko Oskotsky, Ivana Marić, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Biomarkers, Pandemics and Host Response Treatment
David S. Fedson
Journal of Nursing & Healthcare (2024) Vol. 9, Iss. 2, pp. 01-15
Open Access
Clinical and Prognostic Significance of Baseline Serum Vitamin D Levels in Hospitalized Egyptian Covid-19 Patients
Sadek Mostafa, Shaymaa A. Mohammed, Salwa I. Elshennawy, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 8063-8070
Open Access | Times Cited: 2
Page 1

Scroll to top